NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

$3.27  +0.10 (3.16%)
As of 06/27/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/01/2014
Outstanding shares:  42,721,566
Average volume:  276,533
Market cap:   $135,427,364
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -6.84
PB ratio:   16.95
PS ratio:   45.02
Return on equity:   6,909.87%
Net income %:   -1,690.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy